Anthony Catalano

Etex Corp. manufactures calcium phosphate biomaterials. Its products are used for bone graft substitutes, reconstruction of skeletal defects, orthopedic, spine indications, and orthopedic implants. The company was founded by D. Duke Lee in 1989 and is headquartered in Cambridge, MA.

VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas.

IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT.

Nova Biomedical Corp. develops and manufactures blood analyzers. Its products include automated chemistry analyzers for analysis of nutrients, metabolites, and gases in cell culture and fermentation. The company was founded in 1976 by Robert L. Coleman and is headquartered in Waltham, MA.